GB2341319B - Use of compounds in the preparation of a medicament for the therapeutic treatment of a wasting syndrome - Google Patents

Use of compounds in the preparation of a medicament for the therapeutic treatment of a wasting syndrome

Info

Publication number
GB2341319B
GB2341319B GB9929189A GB9929189A GB2341319B GB 2341319 B GB2341319 B GB 2341319B GB 9929189 A GB9929189 A GB 9929189A GB 9929189 A GB9929189 A GB 9929189A GB 2341319 B GB2341319 B GB 2341319B
Authority
GB
United Kingdom
Prior art keywords
medicament
compounds
preparation
therapeutic treatment
wasting syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB9929189A
Other languages
English (en)
Other versions
GB9929189D0 (en
GB2341319A (en
Inventor
Michelle Olga Patricia Visser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cryopreservation Technologies CC
Original Assignee
Cryopreservation Technologies CC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/874,425 external-priority patent/US5935597A/en
Application filed by Cryopreservation Technologies CC filed Critical Cryopreservation Technologies CC
Publication of GB9929189D0 publication Critical patent/GB9929189D0/en
Publication of GB2341319A publication Critical patent/GB2341319A/en
Application granted granted Critical
Publication of GB2341319B publication Critical patent/GB2341319B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Medical Informatics (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GB9929189A 1997-06-13 1998-06-09 Use of compounds in the preparation of a medicament for the therapeutic treatment of a wasting syndrome Expired - Fee Related GB2341319B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/874,425 US5935597A (en) 1995-12-15 1997-06-13 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes
PCT/US1998/011956 WO1998056325A1 (en) 1997-06-13 1998-06-09 Drug delivery devices and methods for treatment of viral and microbial infections and wasting syndromes

Publications (3)

Publication Number Publication Date
GB9929189D0 GB9929189D0 (en) 2000-02-02
GB2341319A GB2341319A (en) 2000-03-15
GB2341319B true GB2341319B (en) 2002-02-27

Family

ID=25363728

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9929189A Expired - Fee Related GB2341319B (en) 1997-06-13 1998-06-09 Use of compounds in the preparation of a medicament for the therapeutic treatment of a wasting syndrome

Country Status (34)

Country Link
EP (1) EP1011567A4 (ko)
JP (1) JP4531141B2 (ko)
KR (1) KR20010013709A (ko)
CN (1) CN1260703A (ko)
AP (1) AP1629A (ko)
AR (1) AR012970A1 (ko)
AU (1) AU7831598A (ko)
BG (1) BG103997A (ko)
BR (1) BR9810095A (ko)
CA (1) CA2295176A1 (ko)
CZ (1) CZ298510B6 (ko)
EA (1) EA200000011A1 (ko)
EE (1) EE9900562A (ko)
ES (1) ES2161187B1 (ko)
FI (1) FI19992648A (ko)
GB (1) GB2341319B (ko)
HU (1) HUP0003034A2 (ko)
ID (1) ID23516A (ko)
IL (2) IL133396A0 (ko)
IS (1) IS5289A (ko)
LT (1) LT4714B (ko)
LV (1) LV12490B (ko)
NO (1) NO996117L (ko)
NZ (1) NZ501669A (ko)
OA (1) OA11307A (ko)
PL (1) PL196256B1 (ko)
RO (1) RO121252B1 (ko)
SI (1) SI20191A (ko)
SK (1) SK172299A3 (ko)
TN (1) TNSN98086A1 (ko)
TR (1) TR200000540T2 (ko)
WO (1) WO1998056325A1 (ko)
YU (1) YU66099A (ko)
ZA (1) ZA984649B (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070212402A1 (en) * 2003-12-05 2007-09-13 Rooven Qainton V Patch

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5135480A (en) * 1986-07-10 1992-08-04 Elan Transdermal Limited Transdermal drug delivery device
US5359131A (en) * 1992-02-20 1994-10-25 Merrell Dow Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
EP0966196A1 (en) * 1995-12-15 1999-12-29 Cryopreservation Technologies CC Composition for organ cryopreservation and treatment of viral and bacterial infections

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5028435A (en) * 1989-05-22 1991-07-02 Advanced Polymer Systems, Inc. System and method for transdermal drug delivery
US5624912A (en) * 1991-08-21 1997-04-29 Burcoglu; Arsinur Method of treating HIV infection and related secondary infections with defibrotide

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5135480A (en) * 1986-07-10 1992-08-04 Elan Transdermal Limited Transdermal drug delivery device
US4855294A (en) * 1988-09-06 1989-08-08 Theratech, Inc. Method for reducing skin irritation associated with drug/penetration enhancer compositions
US5534260A (en) * 1989-02-23 1996-07-09 University Of Utah Percutaneous drug delivery system
US5359131A (en) * 1992-02-20 1994-10-25 Merrell Dow Pharmaceuticals Inc. Sulfonic acid derivatives in the treatment of viral diseases
EP0966196A1 (en) * 1995-12-15 1999-12-29 Cryopreservation Technologies CC Composition for organ cryopreservation and treatment of viral and bacterial infections

Also Published As

Publication number Publication date
HUP0003034A2 (hu) 2000-12-28
YU66099A (sh) 2002-10-18
KR20010013709A (ko) 2001-02-26
LT99148A (en) 2000-07-25
PL196256B1 (pl) 2007-12-31
LT4714B (lt) 2000-10-25
CN1260703A (zh) 2000-07-19
ES2161187A1 (es) 2001-11-16
WO1998056325A1 (en) 1998-12-17
PL338439A1 (en) 2000-11-06
IL133396A0 (en) 2001-04-30
TR200000540T2 (tr) 2000-09-21
IS5289A (is) 1999-12-08
CZ9904473A3 (cs) 2001-03-14
NZ501669A (en) 2001-09-28
CA2295176A1 (en) 1998-12-17
NO996117D0 (no) 1999-12-10
IL133396A (en) 2006-10-05
AP9901708A0 (en) 1999-12-31
ZA984649B (en) 1999-12-17
TNSN98086A1 (fr) 2005-03-15
OA11307A (en) 2003-10-24
RO121252B1 (ro) 2007-02-28
EA200000011A1 (ru) 2000-08-28
NO996117L (no) 2000-02-11
AR012970A1 (es) 2000-11-22
JP4531141B2 (ja) 2010-08-25
ES2161187B1 (es) 2003-08-16
SI20191A (sl) 2000-10-31
GB9929189D0 (en) 2000-02-02
EE9900562A (et) 2000-06-15
AP1629A (en) 2006-07-11
EP1011567A1 (en) 2000-06-28
LV12490B (en) 2000-12-20
EP1011567A4 (en) 2000-06-28
AU7831598A (en) 1998-12-30
JP2002511862A (ja) 2002-04-16
BG103997A (en) 2001-07-31
CZ298510B6 (cs) 2007-10-24
SK172299A3 (en) 2000-09-12
GB2341319A (en) 2000-03-15
FI19992648A (fi) 2000-02-03
LV12490A (en) 2000-06-20
ID23516A (id) 2000-04-27
BR9810095A (pt) 2001-11-13

Similar Documents

Publication Publication Date Title
IL174732A0 (en) Use of crystal modification of a n-phenyl-2-pyrimidineamine derivative in the preparation of a medicament for the treatment of restenosis
EP0770021A4 (en) DISTRIBUTOR OF MEDICINES IN UNIT DOSES USING APPLICATORS
HK1034664A1 (en) Therapeutic formulation for administering tolterodine with controlled release
CY2007001I1 (el) Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη
PL342515A1 (en) Drug administering device
IL130784A0 (en) Use of an anti-cd40l compound in the manufacture of a medicament for treating a patient with immune complex disease and pharmaceutical compositions containing the same
EP0711559A3 (en) Use of phosphatidylserines for the manufacture of a medicament for improving brain activity
IL119894A (en) Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis
HK1020523A1 (en) Uniform drug delivery therapy
GB9418064D0 (en) Medicament administration inhaler
HUP0002048A3 (en) Cd154 blockade therapy for therapeutic protein inhibitor syndrome
HUP0001263A3 (en) Methods of therapeutic administration of anti-cd4ol compounds
EP1014992A4 (en) USE OF DELTA 5-ANDROSTENES IN THE TREATMENT OF HIV-RELATED LOSS SYNDROME
HUP0201405A2 (en) Pharmaceutical composition for therapeutic use of melatonin
PT879054E (pt) Aplicação de derivados de pirrolidina na preparação de medicamentos para o tratamento do abuso de drogas
PL337807A1 (en) Sertralin dosage formulation in the form of a gelatine-encapsulated solution
GB2341319B (en) Use of compounds in the preparation of a medicament for the therapeutic treatment of a wasting syndrome
IL112391A0 (en) A medicament in dosage unit form
HUP0102191A3 (en) Use of oxazolidinones for the preparation of a medicament for transdermal delivery
PL325509A1 (en) Therapeutic agent for oral administration
IL161114A (en) Use of specific dose of fondaparinux sodium in the preparation of a medicament for the treatment of acs
GB9704174D0 (en) Agent for medical treatment
IL117465A (en) Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis
SI1083900T1 (en) Use of of oxazolidinones for the preparation of a medicament for transdermal delivery
HUP0102868A3 (en) Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 20020609

REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1026598

Country of ref document: HK